These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8827809

  • 21. Measurement of effective renal plasma flow: a comparison of methods.
    Fine EJ, Axelrod M, Gorkin J, Saleemi K, Blaufox MD.
    J Nucl Med; 1987 Sep; 28(9):1393-400. PubMed ID: 3305805
    [Abstract] [Full Text] [Related]

  • 22. A simplified method for the routine determination of effective renal plasma flow.
    Floyd JL, Jackson DE, Thomas JM.
    Clin Nucl Med; 1986 Nov; 11(11):758-9. PubMed ID: 3791782
    [Abstract] [Full Text] [Related]

  • 23. [Renogram and cystogram using 131I-orthoiodohippurate (131I-OIH) and estimation of the effective renal plasma flow volume (ERPF)].
    Maeda M, Yamaguchi M, Hasegawa R, Yoshida H.
    Kaku Igaku; 1983 May; 20(4):391-8. PubMed ID: 6632366
    [No Abstract] [Full Text] [Related]

  • 24. Evaluation of (123)I-orthoiodohippurate single kidney clearance rate by renal sequential scintigraphy in a large cohort of likely normal subjects aged between 0 and 18 years.
    Imperiale A, Olianti C, Comis G, La Cava G.
    Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1483-90. PubMed ID: 16645840
    [Abstract] [Full Text] [Related]

  • 25. How gender and age affect iodine-131-OIH and technetium-99m-MAG3 clearance.
    Bagni B, Bagni I, Orsolon P, Corazzari T.
    J Nucl Med Technol; 2000 Sep; 28(3):156-8. PubMed ID: 11001496
    [Abstract] [Full Text] [Related]

  • 26. Technetium-99m L,L-ethylenedicysteine clearance and correlation with iodine-125 orthoiodohippurate for the determination of effective renal plasma flow.
    Stoffel M, Jamar F, Van Nerom C, Verbruggen A, Besse T, Squifflet JP, Beckers C.
    Eur J Nucl Med; 1996 Apr; 23(4):365-70. PubMed ID: 8612654
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Assessment of total and divided renal plasma flow by 123I-hippuran renography.
    Mackay A, Eadie AS, Cumming AM, Graham AG, Adams FG, Horton PW.
    Kidney Int; 1981 Jan; 19(1):49-57. PubMed ID: 7218668
    [Abstract] [Full Text] [Related]

  • 30. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
    Ozker K, Onsel C, Kabasakal L, Sayman HB, Uslu I, Bozluolçay S, Cansiz T, Kapicioğlu T, Urgancioğlu I.
    J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Clinical evaluation of 123I-orthoiodohippurate (123I-OIH) for diagnosis of renal function: dose finding study].
    Fukuchi M, Ishimura J, Yamashita M, Ishihara K, Matsui R, Kanegawa K, Ikekubo K, Hino M.
    Hinyokika Kiyo; 1990 Feb; 36(2):197-205. PubMed ID: 2343814
    [Abstract] [Full Text] [Related]

  • 33. Comparison of effective renal plasma flow (ERPF) and endogenous creatinine clearance (Ccr) in evaluation of the differential kidney function: an in vivo study.
    Lee YH, Liu RS, Chen MT, Yeh PS, Huang JK, Chang LS.
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Mar; 49(3):147-52. PubMed ID: 1316204
    [Abstract] [Full Text] [Related]

  • 34. Off-site determinations of effective renal plasma flow using technetium-99m-MAG3 and single blood sampling.
    Vines D, Denhartog P, Kwan D, Ichise M.
    J Nucl Med Technol; 1998 Mar; 26(1):23-5. PubMed ID: 9549688
    [Abstract] [Full Text] [Related]

  • 35. [Nuclear medicine diagnosis of kidney diseases].
    Ogris E.
    Wien Med Wochenschr; 1986 Jan 31; 136(1-2):19-26. PubMed ID: 3515771
    [Abstract] [Full Text] [Related]

  • 36. Renal clearance and extraction parameters of ortho-iodohippurate (I-123) compared with OIH(I-131) and PAH.
    Stadalnik RC, Vogel JM, Jansholt AL, Krohn KA, Matolo NM, Lagunas-Solar MC, Zielinski FW.
    J Nucl Med; 1980 Feb 31; 21(2):168-70. PubMed ID: 7356755
    [Abstract] [Full Text] [Related]

  • 37. Iodine-131 Hippuran for the estimation of renal plasma flow: requirements for radiochemical purity.
    Kengen RA, Meijer S, van Zanten AK, Beekhuis H, Kosterink JG, Albertus Piers D.
    Eur J Nucl Med; 1995 Jul 31; 22(7):678-81. PubMed ID: 7498230
    [Abstract] [Full Text] [Related]

  • 38. Pediatric renal iodine-123 orthoiodohippurate dosimetry.
    Marcus CS, Kuperus JH.
    J Nucl Med; 1985 Oct 31; 26(10):1211-4. PubMed ID: 3900309
    [Abstract] [Full Text] [Related]

  • 39. I-131 orthoiodohippurate assessment of renal function after heart transplantation.
    Kurtek RW, Tauxe WN, Lai KK, Fung JJ.
    Clin Nucl Med; 1999 Feb 31; 24(2):117-9. PubMed ID: 9988071
    [Abstract] [Full Text] [Related]

  • 40. New formulas for the calculation of effective renal plasma flow.
    Tauxe WN, Dubovsky EV, Kidd T, Diaz F, Smith LR.
    Eur J Nucl Med; 1982 Feb 31; 7(2):51-4. PubMed ID: 7084268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.